© Copyright 2012, vLex. All Rights Reserved.
- Language
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
The International Cooperation on Harmonization of Technical Requirements for the Registration of Veterinary Medicinal Products (VICH) has developed a draft guideline titled ``Testing for the Detection of Mycoplasma Contamination.'' This draft guideline identifies stages of manufacture where products are to be tested and test procedures used to detect the presence of Mycoplasma contamination. Because the guidelines apply to final product and master seed/cell testing in veterinary vaccines regulated by the Animal and Plant Health Inspection Service under the Virus-Serum-Toxin Act, we are requesting comments on the scope of the guideline and its provisions so that we may include any relevant public input on the draft in the Agency's comments to the VICH Steering Committee.
GAITHERSBURG, Md., June 30 /PRNewswire-USNewswire/ -- In recognition of its leadership in the optimization, validation and routine use of non-animal testing methods, The Institute for In Vitro Sciences (IIVS), Inc. has been awarded the first Mark Twain Ethical Science Award. This honor, presented by People for the Ethical Treatment of Animals (PETA), recognizes IIVS for its successes in helping hundreds of companies world-wide utilize testing strategies that minimize the use of animals, while at the same time maintain or improve the current level of safety for the public. IIVS is a non-profit organization operating as a center of excellence for in vitro (non-animal) methods used for product safety testing purposes. IIVS's knowledge of the science and application of alternatives to anima...
OREM -- At the request of animal rights activists, Utah-based juicemaker Tahitian Noni International announced this week that it will cease funding animal testing of its product. The announcement came after months of interaction with representatives from People for the Ethical Treatment of Animals.
... molecules and large, biological products produced by living organisms. In both instances, t...) that the type and amount of analyses and testing required to demonstrate biosimilarity will be dete...It may include consideration of animal toxicity, human pharmacokinetics, human pharmacody...
A Madison company that's developing a radioactive molecule to track and destroy tumors will announce today it has raised $13 million from a group of Wisconsin-based venture capitalists and angel investors. Cellectar Inc. will use the money to start a clinical trial for its lead cancer product, known as CLR 1404. In animal testing, the compound was retained in 41 tumor types, the company said. In three pre-clinical experiments with different animals, the compound showed anti-tumor activity in breast, prostate and lung cancer tumors, according to Cellectar.
We are advising the public that the Animal and Plant Health Inspection Service has prepared an environmental assessment concerning authorization to ship for the purpose of field testing, and then to field test, an unlicensed Swine Influenza Vaccine, RNA. The environmental assessment, which is based on a risk analysis prepared to assess the risks associated with the field testing of this vaccine, examines the potential effects that field testing this veterinary vaccine could have on the quality of the human environment. Based on the risk analysis, we have reached a preliminary determination that field testing this veterinary vaccine will not have a significant impact on the quality of the human environment, and that an environmental impact statement need not be prepared. We intend to aut...
...Veterinary Biological Product license for this vaccine, provided the field test ...
We are advising the public that the Animal and Plant Health Inspection Service has prepared an environmental assessment concerning authorization to ship for the purpose of field testing, and then to field test, an unlicensed Feline Interleukin-2 Immunomodulator, Live Canarypox Vector. The environmental assessment, which is based on a risk analysis prepared to assess the risks associated with the field testing of this vaccine, examines the potential effects that field testing this veterinary vaccine could have on the quality of the human environment. Based on the risk analysis, we have reached a preliminary determination that field testing this veterinary vaccine will not have a significant impact on the quality of the human environment, and that an environmental impact statement need no...
...Veterinary Biological Product license for this vaccine, provided the field test ...
One of the world's most confrontational animal rights groups is quietly researching product-and chemical-testing methods with the aim of making animal-based tests obsolete. The research, said Jessica Sandler, director of regulatory testing for People for the Ethical Treatment of Animals (PETA), focuses on a system owned by the California-based Hurel Corp.
...While the firm had enlisted an outside testing agency to evaluate the toxicity of the product, th... independent testing agency to conduct live animal acute toxicity testing (``live animal testing'') o...
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company